OR WAIT null SECS
Kyle Staller, MD, MPH, is a gastroenterologist and the director of the Gastrointestinal Motility Laboratory at Mass General.
October 15, 2026
Video
GI health care use still fell among patients who had already tried another IBS-C drug, per a real world ACG 2026 analysis.
October 14, 2026
A real world analysis of 470 patients presented at ACG 2026 found median GI visits fell from 4.5 to 3.0 in the year after initiation
May 19, 2026
Kyle Staller, MD, MPH, explains new real-world data showing 41% of IBS-C patients change treatments at least once, with each switch driving higher HCRU and provider portal burden.
October 01, 2025
Staller describes key takeaways from the 12 conditional recommendations made in the American Gastroenterological Association’s new gastroparesis guideline.